Context Urothelial carcinoma is considered a pan-urothelial disease. As such, the remnant
urothelium in the upper urinary tract and urethra following radical cystectomy (RC) remains …

Radical treatment of many solid tumours has moved from surgery to multimodal organ
preservation strategies combining systemic and local treatments. Trimodality bladder …

Background Concerns remain whether robot-assisted radical cystectomy (RARC)
compromises survival because of inadequate oncologic resection or alteration of recurrence …

One of the promising possibilities of the clinical application of cold plasma, so-called cold
atmospheric plasma (CAP), is its application on malignant cells and cancer tissue using its …

Methods All relevant articles on MIBC and metastatic bladder cancer were sought using a
combination of Medline and EMBASE searches. The search strategy involved the following …

This initiative was undertaken in response to concerns regarding the variation in
management and in outcomes of patients with bladder cancer throughout centres and …

Objective Patients treated with radical cystectomy (RC) due to bladder cancer (BCa) face
high risk of clinical recurrence. The aim of our study was to describe recurrence patterns and …

Background Radical cystectomy (RC) associated with pelvic lymph node dissection (PLND)
is the most common local therapy in the management of non-metastatic muscle invasive …

Administration of neoadjuvant chemotherapy preceding radical cystectomy in patients with
bladder cancer remains a matter of debate. Results of prospective, randomized studies have …

Background: Evidence shows that wait times before bladder cancer surgery have been
increasing, and wait time can negatively affect survival. We aimed to determine if a long …